read more

Decision Resources, Inc., acquired Fingertip Formulary

Education

1

Healthcare

13

Media & Marketing

15

Online & Mobile

12

Private Equity

9
Education

Professional Training Technology

1
Healthcare

Pharma Information

10

Medical Information

3
Media & Marketing

B2B Publishing and Information

7

Internet Media

8
Online & Mobile

E-Content

11

E-Marketing & Search

1
Search Breadth
 
 
 
 
 
 
 
 
 
 
 
 
Narrower
Broader
save search to my segments

Healthcare

1

Media & Marketing

1

Online & Mobile

1

Private Equity

1
Healthcare

Pharma Information

1
Media & Marketing

Internet Media

1
Online & Mobile

E-Content

1

Healthcare

13

Media & Marketing

12

Software

1

Online & Mobile

4

Private Equity

11
Healthcare

Pharma Information

9

Medical Information

2

Pharma IT

1

Pharma Business Services

1
Media & Marketing

B2B Publishing and Information

4

Internet Media

3

Marketing

5
Software

Niche Software

1
Online & Mobile

E-Content

4

Healthcare

13

Media & Marketing

15

Online & Mobile

8

Private Equity

6
Healthcare

Pharma Information

12

Pharma Business Services

1
Media & Marketing

B2B Publishing and Information

10

Internet Media

4

Marketing

1
Online & Mobile

E-Content

7

E-Marketing & Search

1
Search Breadth
 
 
 
 
 
 
 
 
 
 
 
 
Narrower
Broader
save search to my segments

note: a single transaction may fall into multiple segments
view all transactions
Basic features include:
  • Weekly Alerts
  • View Full Listing of Recent Deals
  • Trends
Premium features include:
  • Daily-Weekly-Monthly Custom Alerts
  • Drill down on comparable historical deals
  • Search for target or buyer by name
  • See historical deals by buyer or seller
  • Buyer and seller watch lists
  • Custom Segments
  • Bookmark deals
  • Export Listings to PDF
  • buyer to watch list
  • seller to watch list
  • Email
  • LinkedIn
  • Facebook
  • Twitter
  • Google Plus
  • Yahoo Buzz
  • Delicious
  • Digg
  • StumbleUpon
  • Newsvine
  • Reddit
  • Technorati

Like Fingertip Formulary

closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target parent: Providence Equity Partners Inc.
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2010 via BusinessWire

Canon Communications, LLC, acquired Pharmalot

synopsis: Canon Communications LLC, announced that it has acquired Pharmalot. As part of the acquisition, Pharmalot’s founder, Ed Silverman, will join Canon as an Editor at Large in the Pharmaceutical Media Group and will continue as Pharmalot’s Editor.
buyer parent:Spectrum Equity Investors
buyer: Canon Communications, LLC
Canon Communications LLC produces tradeshows and conferences for both U.S. and international markets. Canon also publishes magazines and digital media for medical devices, microelectronics, plastics processing, packaging, and other advanced design and manufacturing markets.
target: Pharmalot
Pharmalot is an influential blog focused on news and information in the pharmaceutical industry. Pharmalot is written by Ed Silverman, a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2008 via BNC Analysis

Alta Communications, acquired CompareNetworks, Inc.

synopsis: Alta Communications, a private equity firm focused on the media and telecommunications industries, acquired a controlling interest in Compare Networks.
buyer: Alta Communications
Alta Communications is a Boston-based private equity firm specializing in equity investments in media and communications companies. Alta Communications has a very successful track record and is extremely active, having invested in over 100 media and telecommunications companies.
target: CompareNetworks, Inc.
CompareNetworks, Inc. is a leading global media company for the life science and healthcare industries. The CompareNetworks websites assist health and life science professionals in making informed purchasing decisions by offering a long-needed source of product information and industry news.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BusinessWire

Trifecta Multimedical, acquired Virtual Clinical Solutions, Inc.

synopsis: Trifecta Multimedical, one of the largest global providers of online clinical training solutions, announced the acquisition of Virtual Clinical Solutions (VCS). VCS is a specialist in providing virtual meetings and on-demand training content for the healthcare and pharmaceutical industries.
buyer: Trifecta Multimedical
Trifecta Multimedical is a global leader in online investigator training. Trifecta Multimedical’s solutions have been proven to decrease time for site readiness, accelerate enrollment and improve communication between sponsors, sites and clinical research associates on hundreds of clinical trials.
target: Virtual Clinical Solutions, Inc.
A leading global provider of online clinical training solutions, Virtual Clinical Solutions provides services in 120 countries, specializing in the delivery of efficient, cost-effective training of investigational sites and study teams, through virtual meetings and on-demand training content.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent:Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries.
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent:Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes.
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent:The Thomson Corporation
buyer: Thomson Pharma
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide.
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent:Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations.
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments.
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2011 via Market Wire

CompareNetworks, Inc., acquired Russell Publishing LLC

synopsis: CompareNetworks, Inc. announced the acquisition of Russell Publishing LLC, complementing the company's innovative online marketplaces with industry-leading pharmaceutical publications. Russell Publishing's titles include American Pharmaceutical Review, Pharmaceutical Outsourcing and International Drug Discovery.
buyer parent:Alta Communications
buyer: CompareNetworks, Inc.
CompareNetworks operates targeted, online, B2B marketplaces for professionals worldwide. The company integrates online marketplaces, email newsletters, award-winning video, whitepapers and editorial content to bring buyers and sellers together.
target: Russell Publishing LLC
Russell Publishing LLC, a privately held company founded in 1998 and based in Indianapolis, IN, is one of the leading publishers of life science B2B publications in the world. The company's three titles and websites cover all aspects of the pharmaceutical and biopharmaceutical pipeline.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/9/2009 via Company Press Release

PDR Network, acquired Physicians' Desk Reference

synopsis: PDR Network acquires Physicians' Desk Reference, the most routinely used drug information source in the U.S., the primary means by which manufacturers fulfill their ‘duty to warn’ prescribers about drug details including safety issues, and the primary drug information source routinely cited in drug-related litigation.
buyer parent:Lee Equity Partners, LLC
buyer: PDR Network
PDR Network includes the Physicians' Desk Reference, the most commonly used drug information reference available in the US, and the Health Care Notification Network, the only service that provides electronic delivery of important FDA-mandated and product-related patient safety alerts to physicians.
target parent: Thomson Reuters
target: Physicians' Desk Reference
The Physicians' Desk Reference has been the authoritative source for prescribing information for over 63 years. Delivered in multiple formats print and electronically, PDR provides instant access to drug labeling information that prescribers use throughout their daily workflow.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/2/2008 via BusinessWire

Jones & Bartlett Publishers, Inc., acquired Tarascon Publishing

synopsis: Jones and Bartlett Publishers announces the acquisition of Tarascon Publishing, one of the world’s leading publishers of portable medical reference products. Tarascon is the third medical publishing company acquired by J&B in 2008. Terms of the agreement were not disclosed.
buyer parent:Providence Equity Partners Inc.
buyer: Jones & Bartlett Publishers, Inc.
Educating tens of millions of people worldwide, Jones and Bartlett Publishers is a global leader in educational publishing, providing unique textbooks, reference products, testing and assessment services, and training materials in both print and digital formats.
target: Tarascon Publishing
Founded by Dr. Steven Green, Tarascon Publishing has developed a full range of information rich clinical pocketbooks and drug guides for students, physicians, nurses, other healthcare professionals, and pharmaceutical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2008 via Market Wire

Hearst Business Media, acquired Map of Medicine

synopsis: Hearst Corporation announced the acquisition of U.K.-based Map of Medicine, a leading provider of evidence-based health-care resources designed to help health practitioners make sound decisions by following accessible clinical information on a range of relevant medical issues.
buyer parent:The Hearst Corporation
buyer: Hearst Business Media
Hearst Business Media (HBM), an operating group of The Hearst Corporation, operates more than 20 business-to-business information services, electronic databases, and publications. The Group has significant holdings in the automotive, electronic, and medical/pharmaceutical industries.
target parent: Informa plc
target: Map of Medicine
The Map of Medicine is a web-based visual representation of evidence-based patient care journeys covering 28 medical specialties and 390 pathways.
price ($mm)
$70
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/23/2009 via Company Press Release

Physicians Interactive, acquired Skyscape Inc.

synopsis: Physicians Interactive LLC (PI), the leading digital sales and health marketing partner for life sciences companies, announced the acquisition of Skyscape Inc., the world’s No. 1 service for trusted medical information delivered via mobile devices and the Internet. Skyscape is now a wholly owned subsidiary of PI.
buyer parent:Perseus, L.L.C.
buyer: Physicians Interactive
Physicians Interactive builds an electronic dialogue with healthcare professionals by utilizing technology platforms and online interactive programs to deliver valuable education and promotion about medical products and disease states.
target: Skyscape Inc.
Skyscape® is the worldwide leading service for trusted medical information by specialty for mobile devices. Skyscape's service enables healthcare practitioners to tailor their experience from the most trusted medical information available and delivers it in an intuitive manner.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/7/2010 via BusinessWire

Vestar Capital Partners, acquired Health Grades, Inc.

synopsis: Affiliates of Vestar Capital Partners V, L.P. formed for the purpose of acquiring Health Grades, Inc., and HealthGrades announced the successful completion of the cash tender offer for all of the outstanding shares of common stock of HealthGrades at a purchase price of $8.20 per share in cash.
buyer: Vestar Capital Partners
Vestar Capital Partners is a leading global private equity firm. For 20 years, Vestar has been seeking out talented management teams and supporting their entrepreneurial dreams, allowing them to run their companies as owners, with an eye toward long-term value creation.
target: Health Grades, Inc.(HGRD:$58.17)
HealthGrades is the leading independent healthcare ratings organization, providing quality ratings, profiles and cost information on the nation’s hospitals, physicians, nursing homes and prescription drugs.
price($mm)[EV]
$250 [$226]
rev ($mm)
$58
EBITDA ($mm)
$13
EV / rev
4.4x
EV / EBITDA
19.6x
closed 11/29/2012 via PR Newswire

HealthTap, purchased Avvo Health from Avvo, Inc.

synopsis: HealthTap, the premier mobile health platform that connects users with top doctors and free answers to health questions, and Avvo, Inc., the web's largest expert-only legal Q&A forum and directory, announced that HealthTap has acquired the health business of Avvo, Inc.
buyer: HealthTap
HealthTap is an Interactive Health Network that connects thousands of North America's best physicians with users to provide trusted answers to health questions anytime, anywhere.
seller: Avvo, Inc.
Avvo is the web's largest expert-only legal Q&A forum and directory and the most successful lawyer marketing platform in the industry, delivering hundreds of thousands of contacts from prospective clients every month.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2011 via PR Newswire

Elsevier B.V., acquired Fisterra.com

synopsis: Elsevier has announced the acquisition of Fisterra.com, an award winning, widely used e-clinical reference solution in Spain. Fisterra was launched in 2002 by two primary care doctors and a medical librarian in response to the need for an online short answer Spanish language reference solution to help primary care physicians.
buyer parent:Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals and close to 20,000 book titles.
target: Fisterra.com
Fisterra.com provides access to Fisterrae, an advanced e-clinical reference solution that integrates support resources for health professionals in a local language platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/8/2011 via BusinessWire

Ebix, Inc., acquired A.D.A.M., Inc.

synopsis: Ebix, Inc., a leading international supplier of On-Demand software and E-commerce services to the insurance industry, has announced the closing of the merger of Atlanta based A.D.A.M., Inc., a leading provider of health information and benefits technology solutions in the United States.
buyer: Ebix, Inc.(EBIX:$199.37)
Ebix, Inc., provides end-to-end solutions ranging from infrastructure exchanges, carrier systems, agency systems and BPO services to custom software development for all entities involved in the insurance industry.
target: A.D.A.M., Inc.(ADAM:$27.87)
A.D.A.M., Inc. is a leading provider of consumer health information and benefits technology solutions to healthcare organizations, benefits brokers, employers, consumers, and educational institutions.
price($mm)[EV]
$61 [$62]
rev ($mm)
$28
EBITDA ($mm)
$6
EV / rev
2.4x
EV / EBITDA
10.5x
closed 3/4/2011 via Company Press Release

Elsevier B.V., acquired Shanghai Datong Medical Information Technology Co., Ltd.

synopsis: Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced the acquisition of Shanghai Datong Medical Information Technology Co., Ltd., a leading drug decision support provider in China.
buyer parent:Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals and close to 20,000 book titles.
target: Shanghai Datong Medical Information Technology Co., Ltd.
Shanghai Datong Medical Information Technology Co., Ltd. is a drug decision support provider in China. Datong's flagship product 'Clinical Drug Consultation and Safety Monitoring System' is embedded in the hospital's computerised physician order system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target parent: Providence Equity Partners Inc.
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent:Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent:Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries.
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 4/17/2012 via BusinessWire

Decision Resources Group, acquired Pinsonault Associates, LLC.

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired Pinsonault, a leading provider in offering managed markets-specific business and training solutions to the pharmaceutical and biotech industries.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
target: Pinsonault Associates, LLC.
Pinsonault is dedicated to and focused on delivering high quality, Managed Markets specific, business and training solutions within the pharmaceutical and biotech industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2011 via BusinessWire

Decision Resources Group, acquired PharmaStrat, Inc.

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, has acquired PharmaStrat, the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, insights, advisory services and consulting on important sectors of the healthcare industry.
target: PharmaStrat, Inc.
PharmaStrat is the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. It delivers strategic perspectives and market insight solutions that proactively address challenges and opportunity.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2008 via PR Newswire

Decision Resources, Inc., acquired Manhattan Research, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target: Manhattan Research, Inc.
Manhattan Research is a healthcare market research and advisory services firm, bringing clarity to the market forces, trends, and impacts of physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target parent: Providence Equity Partners Inc.
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via

Decision Resources, Inc., purchased Life Sciences business from Wood Mackenzie

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that it plans to acquire Wood Mackenzie's Life Sciences business.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
seller: Wood Mackenzie
Wood Mackenzie has been providing its unique range of consulting services and research products to the Energy and Life Sciences industries for over 30 years. Our market proposition is based on our ability to provide forward- looking insight that enables our clients to make better business decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments.
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/2/2006 via PR Newswire

Decision Resources, Inc., acquired Millennium Research Group

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced today that it acquired Millennium Research Group, the global authority on medical technology market intelligence.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target: Millennium Research Group
Millennium Research Group is a leading provider of strategic information to the healthcare sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the Company provides its clients with the benefits of its specialized industry expertise through published reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/22/2005 via BusinessWire

HCPro, acquired HealthLeaders, Inc.

synopsis: HCPro, Inc. today announced it has significantly broadened its healthcare publishing lines by acquiring HealthLeaders Media from Decision Resources, Inc. The acquisition includes the monthly HealthLeaders magazine, several general healthcare business email publications, live events and a state-specific healthcare business news service.
buyer parent:The Riverside Company
buyer: HCPro
HCPro is a leading provider of integrated information, education, training, and consulting products and services in the vital areas of healthcare regulation and compliance. The company's mission is to meet the specialized informational, advisory, and educational needs of the healthcare industry.
target parent: Boston Ventures Management, Inc.
target: HealthLeaders, Inc.
HealthLeaders is a leading multi-platform media company dedicated to meeting the business information needs of healthcare executives and professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent:Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
target parent: Providence Equity Partners Inc.
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent:Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent:Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries.
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent:Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes.
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent:The Thomson Corporation
buyer: Thomson Pharma
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide.
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent:Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations.
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries.
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments.
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/21/2010 via Company Press Release

MedMeme LLC, acquired Medical Intelligence Solutions

synopsis: MedMeme, LLC, a leading provider of key opinion leader data and competitive intelligence to the healthcare, pharmaceutical, and biotechnical industries, announced the recent acquisition of Medical Intelligence Solutions (MIS), the world's foremost provider of information on medical meeting content.
buyer: MedMeme LLC
MedMeme™ LLC is a medical opinion leader database company serving the pharmaceutical and biotech community worldwide. MedMeme focuses on providing in-depth, comprehensive, accurate, and actionable competitive intelligence on all aspects of medical research and the experts who work in the field.
target: Medical Intelligence Solutions
Medical Intelligence Solutions (MIS) provides key clinical data presented at domestic and international medical meetings relevant to the development and marketing of pharmaceuticals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2008 via BtoBonline.com

Gemini Healthcare, LLC, acquired MCM Group

synopsis: Marketing agency Gemini Healthcare has acquired MCM Group, a data analytics and benchmarking applications provider. Financial terms of the deal were not disclosed. MCM Group delivers its benchmarks programs through a proprietary platform called Total Resource Utilization that will now be available to Gemini's clients.
buyer: Gemini Healthcare, LLC
Gemini Healthcare, LLC is a healthcare marketing company based in Westbrook, Connecticut.
target: MCM Group
The MCM Group is a healthcare communications organization. We deliver comprehensive marketing, communications and consulting solutions for pharmaceutical and biotech companies. What's uncommon about us? Superior insight.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/30/2007 via Company Press Release

Entelos Inc., acquired Iconix Biosciences, Inc.

synopsis: Entelos, Inc., a leading life sciences company that leverages its proprietary in silico disease models, known as PhysioLab® platforms, to develop drugs and support pharmaceutical R&D, is pleased to announce that it has entered into an agreement to acquire Iconix Biosciences, Inc., a privately held predictive toxicology company
buyer: Entelos Inc.
Entelos partners with pharmaceutical and biotech organizations worldwide to develop effective new treatments for disease and dramatically reduce the time and cost needed to develop them. Using our patented PhysioLab technology, Entelos develops dynamic large-scale computer models of human disease.
target: Iconix Biosciences, Inc.
Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix®)
price ($mm)
$7.73
rev ($mm)
$5
EBITDA ($mm)
EV / rev
6.7x
EV / EBITDA
closed 4/25/2006 via PR Newswire

Thomson Pharma, acquired CMR International

synopsis: The Thomson Corporation today announced that it has completed the acquisition of Centre for Medicines Research International (CMR), the foremost provider of R&D performance metrics to the global pharmaceutical industry. CMR International, based in Epsom in the United Kingdom, is the world leader in global R&D performance measurement.
buyer parent:The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific.
target: CMR International
CMR International is the foremost provider of R&D performance metrics to the global pharmaceutical industry. Our ‘gold standard’ reputation in this field is based on an unrivalled record of assuring the confidentiality of the data we manage and analyse.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2010 via BusinessWire

Canon Communications, LLC, acquired Pharmalot

synopsis: Canon Communications LLC, announced that it has acquired Pharmalot. As part of the acquisition, Pharmalot’s founder, Ed Silverman, will join Canon as an Editor at Large in the Pharmaceutical Media Group and will continue as Pharmalot’s Editor.
buyer parent:Spectrum Equity Investors
buyer: Canon Communications, LLC
Canon Communications LLC produces tradeshows and conferences for both U.S. and international markets. Canon also publishes magazines and digital media for medical devices, microelectronics, plastics processing, packaging, and other advanced design and manufacturing markets.
target: Pharmalot
Pharmalot is an influential blog focused on news and information in the pharmaceutical industry. Pharmalot is written by Ed Silverman, a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent:Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data.
target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/31/2006 via BNC Analysis

Informa plc, acquired Citeline

synopsis: Informa plc, the leading provider of business intelligence and strategic services to the global telecoms and media markets has acquired Citeline, Inc., the leading provider of global clinical trials intelligence to the pharmaceutical industry.
buyer: Informa plc(IFPJF:$1,226.50)
Informa plc is the leading international provider of specialist information and services for the academic and scientific, professional and commercial business communities.
target: Citeline
Citeline developes innovative intelligence solutions for pharmaceutical and biotechnology companies. Citeline enhances the competitive position of its clients by providing actionable information about competitors' worldwide clinical development activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2012 via BusinessWire

LifeMap Sciences, Inc., acquired XenneX, Inc.

synopsis: BioTime, Inc. and its wholly owned subsidiary, LifeMap Sciences, announced that they have completed the acquisition of XenneX, Inc. through a merger of XenneX into LifeMap Sciences. XenneX provides biotechnology, pharmaceutical and other life sciences companies, services and tools to enhance their bio-medical research.
buyer parent:BioTime, Inc.
buyer: LifeMap Sciences, Inc.
LifeMap Sciences, Inc. is developing a discovery platform, including a web-based database, to aid researchers in the use of embryonic stem cells, progenitor cells, and induced pluripotent stem cells for the development of new products and technologies in the emerging field of regenerative medicine.
target: XenneX, Inc.
XenneX, Inc. is a privately held company that is dedicated to providing biotechnology, pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2012 via BNC Analysis

TechCapital Group, acquired iHealthEcon

synopsis: TechCapital Group, Life Science Unit has acquired iHealthEcon, a health economics solutions company that helps life sciences organizations plan, develop and advocate health economics to global payers through e-registry-suite.
buyer: TechCapital Group
Established in 1992, TechCapital Group is a private global investment firm that originates, structures and acts as lead equity investor in equity private placements. The R&D management consulting unit provides decision support tools to advanced scientific based engineering groups.
target: iHealthEcon
iHealthEcon, through e-registry, offers its clients an innovative suite of decision support tools to advance market access by improving the speed and efficiency of collecting health economics and outcomes research registry data in real time to National Health Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BusinessWire

Trifecta Multimedical, acquired Virtual Clinical Solutions, Inc.

synopsis: Trifecta Multimedical, one of the largest global providers of online clinical training solutions, announced the acquisition of Virtual Clinical Solutions (VCS). VCS is a specialist in providing virtual meetings and on-demand training content for the healthcare and pharmaceutical industries.
buyer: Trifecta Multimedical
Trifecta Multimedical is a global leader in online investigator training. Trifecta Multimedical’s solutions have been proven to decrease time for site readiness, accelerate enrollment and improve communication between sponsors, sites and clinical research associates on hundreds of clinical trials.
target: Virtual Clinical Solutions, Inc.
A leading global provider of online clinical training solutions, Virtual Clinical Solutions provides services in 120 countries, specializing in the delivery of efficient, cost-effective training of investigational sites and study teams, through virtual meetings and on-demand training content.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via BusinessWire

Healthnostics, Inc., acquired MedNets, Inc.

synopsis: Healthnostics, Inc. a medical and biotechnology analytics company, today announced the completion of the MedNets.com acquisition, an Internet portal providing healthcare information resources to consumers and professionals.
buyer: Healthnostics, Inc.(hnso:$0.00)
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information.
target: MedNets, Inc.
MedNets, Inc. offers MedExplore, our medical professional and patient Healthcare Information Directory, through our web site. We have gathered over 20,000 healthcare links in our directory, creating the source to the finest medical information on the Internet.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Fingertip Formulary


Fingertip Formulary

Pharmalot

CompareNetworks, Inc.

Virtual Clinical Solutions, Inc.

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

Decision Resources, Inc.

Decision Resources, Inc.

Russell Publishing LLC

Physicians' Desk Reference

Tarascon Publishing

Map of Medicine

Skyscape Inc.

Health Grades, Inc.

Avvo, Inc.

Fisterra.com

A.D.A.M., Inc.

Shanghai Datong Medical Information Technology Co., Ltd.

Fingertip Formulary

Abacus International

Decision Resources Group

Pinsonault Associates, LLC.

PharmaStrat, Inc.

BioTrends Research Group, Inc.

Manhattan Research, Inc.

Fingertip Formulary

Arlington Medical Resources Inc.

Wood Mackenzie

Decision Resources, Inc.

Millennium Research Group

HealthLeaders, Inc.

Decision Resources, Inc.

Fingertip Formulary

Abacus International

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

ERT

Decision Resources, Inc.

Decision Resources, Inc.

Medical Intelligence Solutions

MCM Group

Iconix Biosciences, Inc.

CMR International

Pharmalot

Source Healthcare Analytics, LLC

Citeline

XenneX, Inc.

iHealthEcon

Virtual Clinical Solutions, Inc.

MedNets, Inc.

Geography
Matching Companies
Ticker:
 
 
 
 
 
 
 
 
HealthTap
HealthTap
HealthTap is the best way to connect with the most trusted health information and best doctors. With top-rated web and mobile apps, HealthTap offers immediate and free access to personalized, reliable, and trusted health answers and tips from a network of more than 38,000 U.S.-licensed doctors.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
URCH Publishing, Ltd.
URCH Publishing, Ltd.
URCH Publishing Ltd is an independent business information publisher dedicated to delivering quality information products to the global pharmaceuticals industry. The company is based in London, UK.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Dove Medical Press Ltd.
Dove Medical Press Ltd.
Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
MedMeme LLC
MedMeme LLC
MedMeme™ LLC is a medical opinion leader database company serving the pharmaceutical and biotech community worldwide. MedMeme focuses on providing in-depth, comprehensive, accurate, and actionable competitive intelligence on all aspects of medical research and the experts who work in the field.
year
2007
rev ($mm)
$15.51
EBITDA ($mm)
EBIT ($mm)
$15.51
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
LA-SER Alpha Group Sarl
LA-SER Alpha Group Sarl
LA-SER was founded in 2004, with a mission to bring cutting-edge scientific methodology to evaluate the real-world impact of medicines. Their goal is to find for whom and under which conditions of use the drugs will demonstrate best benefit to patients, with minimal harm.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
XenneX, Inc.
XenneX, Inc.
XenneX, Inc. is a privately held company that is dedicated to providing biotechnology, pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Cambridge Healthtech Institute
Cambridge Healthtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress.
year
2008
rev ($mm)
$15.00
EBITDA ($mm)
$1.00
EBIT ($mm)
Net Income ($mm)
Employees
52
  • drill down
  • watch
Ticker: VIRA
 
 
 
 
 
 
 
 
Viratech Corp.
Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform. Viratech has created a unique platform leveraging the utility of social collaboration, which will allow biotech research the opportunity for the first time to become open sourced.
year
2012
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
International Scientific Communications, Inc.
International Scientific Communications, Inc.
International Scientific Communications, Inc. publishes journals, editorial tabloids, and technical articles on analytical chemistry and life sciences for the chemists and life scientists. Its publications provide news and information in the biotechnology, drug discovery, and many others.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CenterWatch, Inc.
CenterWatch, Inc.
CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites, data about the global clinical trials industry and more.
year
2007
rev ($mm)
$9.00
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
41
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Intellisphere, LLC
Intellisphere, LLC
Intellisphere, LLC is the publisher of the award-winning series of MDNG journals, custom publications, websites, and e-mail newsletters (eDigests). Published in nine editions with a unique, contemporary voice, style, and look, MDNG explores technology, computers, and the Internet.
year
2008
rev ($mm)
$30.00
EBITDA ($mm)
$4.00
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
LA-SER Alpha Group Sarl
LA-SER Alpha Group Sarl
LA-SER was founded in 2004, with a mission to bring cutting-edge scientific methodology to evaluate the real-world impact of medicines. Their goal is to find for whom and under which conditions of use the drugs will demonstrate best benefit to patients, with minimal harm.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
URCH Publishing, Ltd.
URCH Publishing, Ltd.
URCH Publishing Ltd is an independent business information publisher dedicated to delivering quality information products to the global pharmaceuticals industry. The company is based in London, UK.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
XenneX, Inc.
XenneX, Inc.
XenneX, Inc. is a privately held company that is dedicated to providing biotechnology, pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
ePharmaSolutions, Inc.
ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Cambridge Healthtech Institute
Cambridge Healthtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress.
year
2008
rev ($mm)
$15.00
EBITDA ($mm)
$1.00
EBIT ($mm)
Net Income ($mm)
Employees
52
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Altarum Institute
Altarum Institute
Altarum Institute, a nonprofit serving clients in the public and private sectors, integrates objective research and client-centered consulting skills to deliver comprehensive, systems-based solutions that improve health and health care.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: VIRA
 
 
 
 
 
 
 
 
Viratech Corp.
Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform. Viratech has created a unique platform leveraging the utility of social collaboration, which will allow biotech research the opportunity for the first time to become open sourced.
year
2012
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Billian Publishing, Inc.
Billian Publishing, Inc.
Trans World Publishing, Inc. and Billian Publishing, Inc. (an affiliated company) produce consumer and trade magazines, directories, databases and websites for both the North American and International markets.
year
2009
rev ($mm)
$7.00
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CenterWatch, Inc.
CenterWatch, Inc.
CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites, data about the global clinical trials industry and more.
year
2007
rev ($mm)
$9.00
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
41
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Health Language Inc.
Health Language Inc.
Health Language, Inc. specializes in the development, delivery and marketing of software that reduces the complexity of incorporating medical vocabulary and coding standards into healthcare information technology (HCIT) applications.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Trifecta Multimedical
Trifecta Multimedical
Trifecta Multimedical is a global leader in online investigator training. Trifecta Multimedical’s solutions have been proven to decrease time for site readiness, accelerate enrollment and improve communication between sponsors, sites and clinical research associates on hundreds of clinical trials.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Dove Medical Press Ltd.
Dove Medical Press Ltd.
Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
MedMeme LLC
MedMeme LLC
MedMeme™ LLC is a medical opinion leader database company serving the pharmaceutical and biotech community worldwide. MedMeme focuses on providing in-depth, comprehensive, accurate, and actionable competitive intelligence on all aspects of medical research and the experts who work in the field.
year
2007
rev ($mm)
$15.51
EBITDA ($mm)
EBIT ($mm)
$15.51
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Michael J. Hennessy & Associates, Inc.
Michael J. Hennessy & Associates is a healthcare publishing company that reaches nearly every sector of healthcare professionals, providing resources and information to physicians, pharmacists, managed care professionals, and many others.
year
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch

Login

Account Information

Get Premium Access

Premium features include:
  • Daily-Weekly-Monthly Custom Alerts
  • Drill down on comparable historical deals
  • Search for target or buyer by name
  • See historical deals by buyer or seller
  • Buyer and seller watch lists
  • Custom Segments
  • Bookmark deals
  • Export Listings to PDF
Start
Stop